• LuQi Formula, SPTLC2, and Post-MI Remodeling

  2026-08-26

  A 2025 Phytomedicine study identifies SPTLC2-regulated de novo ceramide synthesis as a mechanistic link between myocardial infarction and ventricular remodeling. Using rat and cardiomyocyte models, the authors show that LuQi Formula reduces ceramide accumulation and apoptosis, supporting a pathway-oriented framework for evaluating post-infarction cardiac protection.

• Indazole/Indole Glucagon Receptor Antagonists

  2026-08-25

  This 2015 study introduced indazole- and indole-based glucagon receptor antagonists derived from the pyrazole lead MK-0893. Structure–activity relationship studies produced compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral glucose-lowering activity for GRA 16d in human glucagon receptor mouse models.

• Carvacrol at the Redox–Cell-Cycle Interface

  2026-08-25

  Carvacrol, also known as 5-isopropyl-2-methylphenol, offers translational researchers a useful bridge between TRPA1 redox biology, cell-cycle regulation, and apoptosis research. This article examines how to validate its activity, interpret ROS-dependent channel responses, and avoid overstating mechanistic or clinical maturity.

• Fra2/LCN2 Axis in PM2.5-Aggravated Asthma

  2026-08-24

  A 2026 Redox Biology study identifies the Fra2/LCN2 axis as a mechanistic link between PM2.5 exposure, impaired mitophagy, and ferroptosis in M2 macrophages during asthma exacerbation. Macrophage-specific LCN2 knockdown reduced ferroptosis-associated changes, airway inflammation, and lung-function impairment in asthmatic mice, highlighting a pathway that warrants further translational study.

• tFUS, Nespas/miR-383-3p, and SHP2 in Stroke

  2026-08-23

  A 2025 International Immunopharmacology study shows that low-intensity transcranial focused ultrasound reduces post-stroke neuroinflammation and neurological injury in rats, linking the effect to the Nespas/miR-383-3p/SHP2 pathway and NLRP3 inflammasome suppression. The work provides a mechanistic framework for studying how noninvasive neuromodulation alters microglial signaling, while also defining important limits for pharmacological translation.

• Carvacrol in TRP and Redox Assay Workflows

  2026-08-22

  Carvacrol provides a practical, non-electrophilic TRPA1 agonist for separating reactive oxygen species signaling from agonist chemistry in calcium-imaging experiments. This guide translates recent TRPV1/TRPA1 findings into reproducible workflows while connecting channel pharmacology with cell cycle and apoptosis research.

• AY 9944 dihydrochloride: DHCR7 Workflow

  2026-08-21

  AY 9944 dihydrochloride provides a practical chemical route to perturb DHCR7, accumulate 7-dehydrocholesterol, and examine cholesterol-dependent phenotypes. This guide connects dose-response design, membrane-raft analysis, PBMC immune assays, and the latest dhcr7 knockout evidence while separating validated findings from recommended optimization steps.

• NU7441 (KU-57788) in DNA-PK Research

  2026-08-21

  NU7441 (KU-57788) is a selective DNA-PK inhibitor for testing how DNA repair capacity shapes genotoxic sensitivity, cell-cycle behavior, and tumor response. This guide combines practical oncology workflows with a carefully bounded extension into cytosolic DNA and TDP-43 biology.

• Recombinant Mouse Macrophage Colony Stimulating Factor

  2026-08-20

  Build more reproducible mouse macrophage and osteoclast-progenitor workflows with a tag-free, activity-validated cytokine. This guide connects M-CSF-driven cell preparation to macrophage activation, glycolytic readouts, and pulmonary-fibrosis mechanism studies.

• CLCC1 and Membrane Fusion in Herpesvirus Nuclear Egress

  2026-08-20

  A 2024 bioRxiv study identifies the host protein CLCC1 as an essential factor for membrane fusion during herpes simplex virus 1 nuclear egress, resolving a major gap between viral budding and cytoplasmic capsid release. Its CRISPR-screening and cell-biological evidence also connects herpesvirus egress with nuclear pore complex insertion, suggesting an evolutionarily conserved membrane-remodeling mechanism.

• Angiotensin III: Design a Better RAAS Assay

  2026-08-19

  Angiotensin III is more than a shorter angiotensin II fragment: it is a cleavage-defined probe for separating aldosterone, renin, pressor, and receptor-dependent responses. This guide shows how to use Angiotensin III (human, mouse) in better-controlled RAAS and cross-domain binding assays.

• N2703 in Adipose-Neural Arrhythmia Research

  2026-08-18

  Use 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as a hypothesis-driven probe in multicellular cardiac arrhythmia models. This workflow pairs controlled exposure with calcium, electrophysiology, and pathway-rescue assays to distinguish neural activation from downstream leptin–NPY signaling.

• Disodium bicinchoninate for Reliable Cell Assays

  2026-08-18

  Learn how Disodium bicinchoninate, SKU C6645, can improve aqueous reagent handling and control design in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects product specifications with practical assay optimization while separating documented chemistry from biological claims that require independent validation.

• Safe DNA Gel Stain for Safer Gel Imaging

  2026-08-17

  Safe DNA Gel Stain supports sensitive DNA and RNA detection while helping laboratories reduce reliance on ethidium bromide and UV exposure. Its flexible in-gel or post-electrophoresis formats are especially useful for cloning workflows, RNA quality checks, and nucleic-acid assays connected to cellular-stress research.

• Leucomycin (Kitasamycin): Research Workflows

  2026-08-17

  Leucomycin, also called kitasamycin, is a practical macrolide tool for bacterial growth inhibition assays, translational inhibition studies, and resistance analysis. This guide combines assay-ready handling recommendations with an analytical strategy for monitoring multicomponent drug quality and degradation.

455 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page